Identification of an ataxia telangiectasia-mutated protein mediated surveillance system to regulate Bcl-2 overexpression

Oncogene

Volumn 25, Issue 41, 2006, Pages 5601-5611

  Zhang, J ^a   Lahti, J M ^b   Bruce, A ^a   He, L ^a   Parihar, K ^a   Fan, C ^a   Grenet, J ^b   Liu, L ^c   Kidd, V J ^b   Cormier, S ^a,d   Tang, D ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c ST JOSEPH S HOSPITAL   (Canada)

^d Hill Park Secondary School   (Canada)

Author keywords

ATM; Bcl 2; Oncogene surveillance system; p53

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 2; CYCLOHEXIMIDE; HISTONE H2AX; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN P53; SERINE; SMALL INTERFERING RNA; THREONINE;

ARTICLE; ATAXIA TELANGIECTASIA; CELL GROWTH; CELL HETEROGENEITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG HALF LIFE; DRUG INHIBITION; DRUG SENSITIVITY; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; HEALTH SURVEY; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 33748663038     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209565     Document Type: Article

References (48)

1. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL et al. (1985). Cell 41: 899-906.
2. Bakkenist CJ, Kastan MB. (2003). Nature 421: 499-506.
3. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). Nature 434: 864-870.
4. Brady HJM, Gil-Gonez G, Kirberg J, Berns JM. (1996). EMBO J 15: 6991-7001.
5. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. (2003). Cancer 97: 545-553.
6. Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Horschowski N et al. (1998). J Clin Oncol 16: 2025-2031.
7. Cleary ML, Smith SD, Sklar J. (1986). Cell 47: 19-28.
8. Cong F, Zou X, Hinrichs K, Calame K, Goff SP. (1999). Oncogene 18: 7731-7739.
9. Daidone MG, Luisi A, Veneroni S, Benini E, Silvestrini R. (1999). Endocr Relat Cancer 6: 61-68.
10. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JFM, Zhurinsky J et al. (1999). EMBO J 18: 3054-3063.
11. Damalas A, Kahan S, Shtutman M, Ben Ze'ev A, Oren M. (2001). EMBO J 20: 4912-4922.
12. de La Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T et al. (1999). Cancer Res 59: 5017-5022.
13. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV et al. (1998). Genes Dev 12: 2434-2442.
14. Dimri GP, Itahana K, Acosta M, Campisi J. (2000). Mol Cell Biol 20: 273-285.
15. DiTullio Jr RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J et al. (2002). Nat Cell Biol 4: 998-1002.
16. Gee JM, Robertson JF, Ellis IO, Willsher P, McClelland RA, Hoyle HB et al. (1994). Int J Cancer 59: 619-628.
17. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Nature 434: 907-913.
18. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Buytaert P, Van Marck E. (1995). Br J Cancer 72: 354-360.
19. Huang DCS, O'Reilly LA, Strasser A, Cory S. (1997). EMBO J 15: 4628-4638.
20. Jager JJ, Jansen RLH, Arends JW. (2002). Apoptosis 7: 361-365.
21. Joensuu H, Pylkkanen L, Toikkanen S. (1994). Am J Pathol 145: 1191-1198.
22. Kharbanda S, Pander P, Schofield L, Israels S, Roncinske R, Yoshida K et al. (1997). Proc Natl Acad Sci USA 94: 6939-6942.
23. Kirkin V, Joos S, Zornig M. (2004). Biochem Biophys Acta 1644: 229-249.
24. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. (1997). Science 275: 1132-1136.
25. Ko LJ, Prives C. (1996). Genes Dev 10: 1054-1072.
26. Le MG, Mathieu MC, Douc-Rasy S, Le Bihan ML, Adb El All H, Spielmann M et al. (1999). Int J Cancer 84: 562-567.
27. Lee JH, Paull TT. (2004). Science 304: 93-96.
28. Li Y, Wu D, Chen B, Ingram A, He L, Liu L et al. (2004). Oncogene 23: 7355-7365.
29. Linette GP, Li Y, Roth K, Korsmeyer SJ. (1996). Proc Natl Acad Sci USA 93: 9545-9552.
30. Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M, Syrjanen K. (1995). J Pathol 177: 49-55.
31. Mazel S, Burtrum D, Petrie HT. (1996). J Exp Med 183: 2219-2226.
32. Murphy KL, Kittrell FS, Gay JP, Jager R, Medina D, Rosen JM. (1999). Oncogene 18: 6597-6604.
33. O'Reilly LA, Huang DCS, Strasser A. (1996). EMBO J 15: 6979-6990.
34. Palmero I, Pantoja C, Serrano M. (1998). Nature 395: 125-126.
35. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. (2000). Curr Biol 10: 886-895.
36. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B. (1994). Can Res 54: 3714-3717.
37. Saintigny Y, Dumay A, Lambert S, Lopez BS. (2001). EMBO J 20: 2596-2607.
38. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T et al. (2003). Science 300: 135-139.
39. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Cell 88: 593-602.
40. Shiloh Y. (2003). Nat Rev Cancer 3: 155-168.
41. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M et al. (1994). J Natl Cancer Inst 86: 499-504.
42. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B et al. (2002). J Biol Chem 277: 12710-12717.
43. Tsunimoto Y, Finger LR, Uyinis J, Nowell PC, Croce CM. (1984). Science 266: 1097-1099.
44. Vairo G, Innes KM, Adams JM. (1996). Oncogene 13: 1511-1519.
45. van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM et al. (1996). Br J Cancer 74: 78-85.
46. Yang J, Lie X, Bhalla K, Kim CN, Ibrado AM, Car J et al. (1997). Science 275: 1129-1132.
47. Youn CK, Cho HJ, Kim SH, Kim HB, Kim MH, Chang IY et al. (2005). Nat Cell Biol 7: 137-147.
48. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Genes Dev 12: 2424-2433.